{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:47Z","timestamp":1787027027126,"version":"build-2736575974"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T00:00:00Z","timestamp":1549584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00066","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T06:15:03Z","timestamp":1549606503000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Anti-metastatic Properties of Naproxen-HBTA in a Murine Model of Cutaneous Melanoma"],"prefix":"10.3389","volume":"10","author":[{"given":"Giuseppe","family":"Ercolano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"De Cicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Frecentese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Saccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Corvino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Magli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Fiorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Severino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Calderone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Citi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Ianaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/CMR.0b013e32831d7f52","article-title":"Cox-2 expression in malignant melanoma: a novel prognostic marker?","volume":"19","author":"Becker","year":"2009","journal-title":"Melanoma Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1158\/1940-6207.CAPR-11-0391","article-title":"Aspirin in the chemoprevention of colorectal neoplasia: an overview.","volume":"5","author":"Chan","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/CMR.0b013e3280dec6ac","article-title":"Cyclooxygenase-2 (Cox-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.","volume":"17","author":"Chwirot","year":"2007","journal-title":"Melanoma Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the Braf gene in human cancer.","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.phrs.2016.10.019","article-title":"Atb-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo.","volume":"114","author":"De Cicco","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development.","volume":"6","author":"de Visser","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"B7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1189\/jlb.72.1.9","article-title":"Role of Cxcl1 in tumorigenesis of melanoma.","volume":"72","author":"Dhawan","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/carcin\/bgg046","article-title":"Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against Uv-induced skin tumors in mice.","volume":"24","author":"Fischer","year":"2003","journal-title":"Carcinogenesis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro.","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1002\/cncr.27817","article-title":"Aspirin is associated with lower melanoma risk among postmenopausal caucasian women: the women\u2019s health initiative.","volume":"119","author":"Gamba","year":"2013","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","article-title":"In vivo switching of human melanoma cells between proliferative and invasive states.","volume":"68","author":"Hoek","year":"2008","journal-title":"Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1523-1747.2000.00068.x","article-title":"Matrix metalloproteinases in human melanoma.","volume":"115","author":"Hofmann","year":"2000","journal-title":"J. Invest. Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-1-4020-5133-3_16","article-title":"Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models.","volume":"587","author":"Holmquist","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/CEJ.0b013e328360f479","article-title":"Nonsteroidal anti-inflammatory drug use and the risk of melanoma: a meta-analysis.","volume":"23","author":"Hu","year":"2014","journal-title":"Eur. J. Cancer Prev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the arrive guidelines.","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/01.cmr.0000194430.77643.a0","article-title":"Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression.","volume":"16","author":"Kuzbicki","year":"2006","journal-title":"Melanoma Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-3-319-18144-8_13","article-title":"Role of H2S donors in cancer biology.","volume":"230","author":"Lee","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.celrep.2016.04.073","article-title":"Oncogenic braf-mediated melanoma cell invasion.","volume":"15","author":"Lu","year":"2016","journal-title":"Cell Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation.","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (Arrive etc.): new requirements for publication in Bjp.","volume":"172","author":"McGrath","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5732\/cjc.011.10007","article-title":"Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma.","volume":"30","author":"McKinney","year":"2011","journal-title":"Chin. J. Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1091\/mbc.E10-04-0335","article-title":"The proliferation rate paradox in antimitotic chemotherapy.","volume":"23","author":"Mitchison","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.trecan.2015.07.009","article-title":"Surviving at a distance: organ specific metastasis.","volume":"1","author":"Obenauf","year":"2015","journal-title":"Trends Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/asia.200700282","article-title":"Total synthesis of (+)-yatakemycin.","volume":"3","author":"Okano","year":"2008","journal-title":"Chem. Asian J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/pcmr.12312","article-title":"Role of the cystathionine gamma lyase\/hydrogen sulfide pathway in human melanoma progression.","volume":"28","author":"Panza","year":"2015","journal-title":"Pigment. Cell Melanoma Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"57077","DOI":"10.18632\/oncotarget.10976","article-title":"Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival.","volume":"7","author":"Panza","year":"2016","journal-title":"Oncotarget"},{"key":"B27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bcp.2018.08.008","article-title":"Microrna-143-3p inhibits growth and invasiveness of melanoma cells by targeting cyclooxygenase-2 and inversely correlates with malignant melanoma progression.","volume":"156","author":"Panza","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011123.pub2","article-title":"Systemic treatments for metastatic cutaneous melanoma.","volume":"2","author":"Pasquali","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cell.2010.04.020","article-title":"A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.","volume":"141","author":"Roesch","year":"2010","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/07853890310017053","article-title":"Non steroidal anti-inflammatory drugs and Cox-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality.","volume":"35","author":"Ruegg","year":"2003","journal-title":"Ann. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/aje\/kwq175","article-title":"Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk.","volume":"172","author":"Salinas","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"B32","first-page":"6322","article-title":"Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix\/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.","volume":"61","author":"Seftor","year":"2001","journal-title":"Cancer Res."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers8010017","article-title":"Updates in therapy for advanced melanoma.","volume":"8","author":"Singh","year":"2016","journal-title":"Cancers"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/215158","article-title":"The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies.","volume":"2010","author":"Sobolewski","year":"2010","journal-title":"Int. J. Cell Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1056\/NEJMcibr1013704","article-title":"Resistance to Braf inhibition in melanomas.","volume":"364","author":"Solit","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature13121","article-title":"Reversible and adaptive resistance to Braf(V600E) inhibition in melanoma.","volume":"508","author":"Sun","year":"2014","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000084818","article-title":"Association of regular aspirin use and breast cancer risk.","volume":"68","author":"Swede","year":"2005","journal-title":"Oncology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1582-4934.2003.tb00222.x","article-title":"Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.","volume":"7","author":"Trifan","year":"2003","journal-title":"J. Cell Mol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.tips.2007.09.003","article-title":"Hydrogen sulfide-releasing anti-inflammatory drugs.","volume":"28","author":"Wallace","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1089\/ars.2017.7068","article-title":"Hydrogen sulfide-releasing therapeutics: translation to the clinic.","volume":"28","author":"Wallace","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071522","article-title":"Frequency-risk and duration-risk relationships between aspirin use and gastric cancer: a systematic review and meta-analysis.","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"8890","DOI":"10.18632\/oncotarget.3189","article-title":"Dual effects of collagenase-3 on melanoma: metastasis promotion and disruption of vasculogenic mimicry.","volume":"6","author":"Zhao","year":"2015","journal-title":"Oncotarget"}],"updated-by":[{"DOI":"10.3389\/fphar.2019.00213","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00066\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T09:45:47Z","timestamp":1694598347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00066\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,8]]},"references-count":42,"alternative-id":["10.3389\/fphar.2019.00066"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00066","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,8]]},"article-number":"66"}}